Tech Company Financing Transactions

Light Sciences Oncology Funding Round

Light Sciences Oncology closed a $23.3 million funding round on 11/5/2009. Investors included private investors.

Transaction Overview

Announced On
11/5/2009
Transaction Type
Debt
Amount
$23,300,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
12600 SE 38th St. 111
Bellevue, WA 98006
USA
Email Address
Overview
LSO is currently developing Litx for the treatment of patients with cancers such as hepatoma, metastatic colorectal cancer and glioma, for which the current therapeutic alternatives are of limited efficacy.
Profile
Light Sciences Oncology LinkedIn Company Profile
Social Media
Light Sciences Oncology Company Twitter Account
Company News
Light Sciences Oncology News
Facebook
Light Sciences Oncology on Facebook
YouTube
Light Sciences Oncology on YouTube

Management Team

Title
Name
Email & Social
Chief Financial Officer
Robert Littauer
  Robert Littauer LinkedIn Profile  Robert Littauer Twitter Account  Robert Littauer News  Robert Littauer on Facebook
VP - Regulatory Affairs
Lisa Koch-Hulle
  Lisa Koch-Hulle LinkedIn Profile  Lisa Koch-Hulle Twitter Account  Lisa Koch-Hulle News  Lisa Koch-Hulle on Facebook


 

 

Browse more venture capital transactions:

Prev: 11/5/2009: Everlater venture capital transaction
Next: 11/6/2009: BitWave venture capital transaction

 

Share this article

 


About Our Venture Capital Transactions Database

We do our best to record all VC transactions involving tech companies. All VC database entries on this site are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary